Issues in the process of COVID Vaccine trial 

Synopsis: Many issues have been highlighted in the Phase-3 trial of Bharat Biotech’s COVID-19 vaccines. Those issues could have been avoided after HPV vaccine trial controversy.  Introduction  In a previous case, Human papilloma virus (HPV) vaccine trial was carried out on nearly 23,500 girls in the 10-14 age group in Vadodara, Gujarat and Khammam without proper consent. Almost eight years later the Supreme Court of India criticized the government for its inability to… Continue reading Issues in the process of COVID Vaccine trial 

Preparing workforce for COVID vaccination

Synopsis:India is near vaccine roll out, but it lacks trained healthcare workers for the job.   Introduction   The permission of two COVID-19 vaccinats for emergency use is nearing. There is now hope of an end to the pandemic. But for the administration of vaccination and treatment properly and skillfully, a trained and effective workforce is… Continue reading Preparing workforce for COVID vaccination

Pune hub to track vaccine chain across 41 key cities

News: A command and control centre has been set up at Airports Authority of India Cargo Logistics and Allied Services Company Limited(AAICLAS) to monitor the movement of COVID-19 vaccines. Facts: Source: The Hindu What will AAICLAS do? It will be the nodal body for coordinating air transportation of the vaccines across a network of 41… Continue reading Pune hub to track vaccine chain across 41 key cities

Rising vaccine hesitancy and its solution

Synopsis- As the country readies to implement its COVID-19 vaccination programme, vaccine hesitancy could be an issue that the government needs to address forthwith.  Introduction-  Prime-Minister hailed the approval of two made in India COVID-19 vaccines by the drug regulator and said India is on the threshold of beginning the largest vaccination programme in the world.   However, the COVID-19 vaccination intent is decreasing due to increasing hesitancy.  … Continue reading Rising vaccine hesitancy and its solution

India approves two COVID-19 vaccines for emergency use

News: Central Drugs and Standards Committee(CDSCO) has approved the COVID-19 vaccines COVISHIELD and COVAXIN for restricted use in emergency situations. Initially, the 3 crore medical personnel considered at the highest risk for COVID-19, would be given the vaccine for free. Facts: Source: The Hindu COVISHIELD: It is a vaccine developed by the Serum Institute of India… Continue reading India approves two COVID-19 vaccines for emergency use

Approval to Covaxin, and Covishield Vaccines: Concerns and way forward

This article has been developed based on the Indian Express article “Turning point”. Synopsis- The Drug Controller General of India (DCGI) approved two vaccines — the indigenously developed Covaxin, and Covishield. There are several concerns associated with the hasty approval of vaccines. About Vaccines COVISHIELD: This vaccine is incubated in the laboratories of Oxford University and… Continue reading Approval to Covaxin, and Covishield Vaccines: Concerns and way forward

Concerns of hasty approval to COVID-19 vaccine

Synopsis- Concerns regarding hasty approval granted to the COVID-19 vaccines despites the lack of adequate efficacy data.   Background-  The Drug Controller General of India (DCGI) approved the Subject Expert Committee’s recommendation for emergency use of Serum Institute of India’s Covishieldand Bharat Biotech’s Covaxin.   Covishieldis the same vaccine as developed by Oxford- AstraZeneca, which has got emergency use approval in the… Continue reading Concerns of hasty approval to COVID-19 vaccine

Expert panel grants emergency use authorisation for Oxford vaccine

News: The subject expert committee of Central Drugs Standard Control Organization(CDSCO) has recommended COVID-19 vaccine, Covishield for emergency use authorisation. Facts: COVISHIELD: The Oxford vaccine “AZD1222” is being called Covishield in India. Serum Institute of India(SII) has entered into a manufacturing partnership with Oxford University and Pharma major AstraZeneca to produce this vaccine in India. Technology: Covishield… Continue reading Expert panel grants emergency use authorisation for Oxford vaccine

Health Ministry plans communication strategy

News: Union Health Ministry has released a communication strategy to support the Covid-19 vaccine rollout in India that seeks to disseminate accurate and transparent information by alleviating apprehensions and ensuring its acceptance. Facts: About the strategy: The key areas that will be addressed as part of interventions under the strategy are: Giving information on Covid-19 vaccines Addressing… Continue reading Health Ministry plans communication strategy

Government launches Indian SARS-CoV-2 Genomic Consortia(INSACOG) Group

News: Government of India has launched the Indian SARS-CoV-2 Genomic Consortia Group(INSACOG). Facts: INSACOG: It has been established to monitor the genomic variations in the SARS-CoV-2 on a regular basis through a multi-laboratory network. Composition: It comprises 10 labs (NIBMG Kolkata, ILS Bhubaneswar, NIV Pune, CCS Pune, CCMB Hyderabad, CDFD Hyderabad, InSTEM Bengaluru, NIMHANS Bengaluru, IGIB Delhi… Continue reading Government launches Indian SARS-CoV-2 Genomic Consortia(INSACOG) Group

Union Health Minister nominated to the Board of GAVI, The Vaccine Alliance

Source: PIB News: Union Health Minister of India has been nominated by the Global Alliance for Vaccines and Immunisation(GAVI) as a member of the GAVI Board. Facts: Union Health Minister will be representing the South East Area Regional Office(SEARO)/ Western Pacific Regional Office (WPRO) constituency on the GAVI Board from 1st January,2021 until 31st,December 2023. What… Continue reading Union Health Minister nominated to the Board of GAVI, The Vaccine Alliance

Dry Run and Challenges of Vaccines distribution in India

Synopsis: Indian is one of the world’s leading vaccine manufacturer, thus will have better access to vaccines, but the distribution of manufactured vaccine will prove to be a formidable task. Dry run to test preparedness for the nationwide roll-out of a COVID-19 vaccine kicked off in four States — Assam, Andhra Pradesh, Gujarat and Punjab.… Continue reading Dry Run and Challenges of Vaccines distribution in India

Essentiality of Dry run for COVID vaccines

Synopsis:  Dry runs aimed at testing the planned operations are essential for Covid 19 vaccination process. Background In the coming weeks, the Phase-3 data of two COVID-19 vaccines tested by Indian manufacturers are expected to be submitted for emergency use approval. A countrywide rollout to immunize the four high-risk groups will begin soon in India if any of the vaccines gets… Continue reading Essentiality of Dry run for COVID vaccines

Examining the Strategies involved in Distributing Vaccines

Synopsis: The government must examine the principle underlying the triage scheme for optimised use of resources. Background: Over the next 6-7 months, India plans to vaccinate 300 million people against COVID-19 by prioritizing healthcare workers, other front-line workers and everyone who is above 50 years of age. To vaccinate 300 million people, India requires 600 million doses as… Continue reading Examining the Strategies involved in Distributing Vaccines

UNICEF launches the COVID-19 vaccine market dashboard

Source: UNICEF News: As the designated COVAX procurement coordinator and procurement agent, UNICEF has launched the COVID-19 Vaccine Market Dashboard. Facts: Purpose: The dashboard is an interactive tool for countries, partners and industry to follow the developments of the rapidly evolving COVID-19 vaccine market and the efforts of the COVAX Facility to ensure fair and equitable access… Continue reading UNICEF launches the COVID-19 vaccine market dashboard

India’s First Pneumococcal Conjugate Vaccine “Pneumosil”

Source: The Indian Express News: Union Minister for Health and Family Welfare has inaugurated India’s first pneumococcal conjugate vaccine(PCV) named “Pneumosil”. Facts: Pneumosil: It has been developed by the Serum Institute of India Private Limited (SIIPL) in collaboration with partners like the Bill and Melinda Gates Foundation. Pneumosil was licensed by the Drugs Controller General (India)… Continue reading India’s First Pneumococcal Conjugate Vaccine “Pneumosil”

CoWIN Grand challenge, CoWIN platform and CoWIN App

Source: PIB News: Ministry of Health and Family Welfare(MoHFW) and the Ministry of Electronics and Information Technology (MeitY) has announced its grand challenge for “CoWIN app”. Facts: Aim: To strengthen the COVID-19 Vaccine Intelligence Network (CoWIN) system. Eligibility: Indian tech startups, MSMEs, companies and Limited Liability Partnerships(LLPs) registered in India under Companies Act can apply. Further, teams not… Continue reading CoWIN Grand challenge, CoWIN platform and CoWIN App

India and UK launches Virtual Vaccines Hub

Source: Click here News: India and the UK Government has launched a Virtual Vaccines Hub.  Facts:  Objective: To distribute vaccines for Covid-19 and other deadly viruses by sharing knowledge on clinical trials and regulatory approvals and get vaccines to people who need them most in a safe, secure and energy-efficient way.  Previous such collaboration with the UK:  This… Continue reading India and UK launches Virtual Vaccines Hub

India’s plan for Vaccination

Context: Recently unveiled India’s COVID-19 vaccine policy, should make adequate allowances for ground realities. What is India’s plan on vaccinating people? Strategy to slow the virus spread: With a definitive cure not yet available for COVID-19, vaccines present the world with the best strategy to slow the virus down. India’s plan: The U.K. and the U.S. began vaccinating… Continue reading India’s plan for Vaccination

India’s first indigenous vaccine HGCO19 gets nod for human trials

News: India’s first indigenous mRNA vaccine candidate HGCO19 has received approval from Indian Drug regulators to initiate Phase I/II human clinical trial. Facts: HGCO19: It is a novel mRNA vaccine candidate developed by Gennova, Pune and supported with seed grant under the Ind-CEPI mission of Department of Biotechnology of Ministry of Science & Technology. Additional… Continue reading India’s first indigenous vaccine HGCO19 gets nod for human trials

Asia Pacific Vaccine Access Facility(APVAX)

News: Asian Development Bank(ADB) has launched a $9 billion vaccine initiative—the Asia Pacific Vaccine Access Facility (APVAX). Facts: Aim: To offer rapid and equitable support to its developing members as they procure and deliver effective and safe coronavirus disease (COVID-19) vaccines. Criteria: If a country has to obtain finances under APVAX, then it should fulfil one of the… Continue reading Asia Pacific Vaccine Access Facility(APVAX)

Process and Issues linked to Emergency Use Authorisation (EUA) of COVID Vaccines in India

Emergency Use Authorisation (EUA) This article explains the process of Emergency Use authorization, based on The Indian Express Article “Three Covid-19 vaccine developers seek emergency use approval in India”  Central Drug Standard Control Organisation (CDSCO) has received applications from 3 vaccine developers seeking Emergency Use Authorisation/Approval (EUA) for their candidate Covid-19 vaccines which are still… Continue reading Process and Issues linked to Emergency Use Authorisation (EUA) of COVID Vaccines in India

Authorisation of coronavirus vaccines

Context: Safety and efficacy data for the new vaccine must be known before emergency-use authorisation for vaccines. Why in news? The Pune-based Serum Institute of India has approached the regulator for nod for its vaccine, Covishield, developed by Oxford University. AstraZeneca, which is carrying out the phase-3 trials of the Oxford vaccine in four countries, is… Continue reading Authorisation of coronavirus vaccines

Purpose of the vaccine

Context- The challenges vaccine poses to qualify as a ‘public health’ intervention in India. What is the purpose of vaccination? Individual prevention- – The ability to develop immunity by producing antibodies among those individuals who have taken a vaccine shot. It builds an adaptive immune system To achieve herd immunity– It is a concept used… Continue reading Purpose of the vaccine

Aspects of vaccine distribution

Context: Aspects of vaccine distribution. Background The World Health Organisation (WHO) declared the COVID-19 a pandemic in march 2020 and the most optimistic prediction for a vaccine to be available was by the middle of 2021. Now, the labs around the world are working faster than anticipated and the first vials of a vaccine are likely… Continue reading Aspects of vaccine distribution

Vaccination policy

Context: India’s COVID-19 control plan of actions can be the basis for building a much-needed public health infrastructure. How can vaccine help in eradicating a disease? Preventive medicines: Vaccines play a major role in human mastery over infectious diseases by inducing immunity in individuals. Herd immunity: When a vaccine is rolled out as a national programme and… Continue reading Vaccination policy

Vaccine nationalism

Context- Problems posed by vaccine nationalism and the possible solutions. What is vaccine nationalism the problems posed by vaccine nationalism? Vaccine nationalism occurs when a country manages to secure doses of vaccine for its own citizens or residents before they are made available in other countries. This is done through pre-purchase agreements between a government and a vaccine manufacturer. The… Continue reading Vaccine nationalism

Cold chain infra for covid vaccine

Context: India must improve its cold chain infrastructure to avail benefits of new vaccines Elaborate about the potential covid-19 vaccine by Pfizer? Potential covid vaccine: Multinational drug company Pfizer has announced promising results from its ongoing phase-3 trial of a potential COVID-19 vaccine. Effectiveness in trials: Pfizer, which is using a vaccine candidate by German firm BioNTech, had… Continue reading Cold chain infra for covid vaccine